Disease recurrence may occur in patients with viral hepatitis, tumor disease, autoimmune diseases, and cholestatic liver diseases. With universal recurrence of HCV in all replicative patients, hepatitis C continues to pose one of the greatest challenges for preventing disease progression in the allograft. © 2006 Springer-Verlag/Wien.
CITATION STYLE
Sotiropoulos, G. C., Beckebaum, S., & Gerken, G. (2006). Recurrent diseases after liver transplantation. In Liver and Biliary Tract Surgery: Embryological Anatomy to 3D-Imaging and Transplant Innovations (pp. 568–575). Springer Vienna. https://doi.org/10.1007/978-3-211-49277-2_54
Mendeley helps you to discover research relevant for your work.